Meagan Montesion

3.1k total citations · 2 hit papers
46 papers, 1.4k citations indexed

About

Meagan Montesion is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Meagan Montesion has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 21 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Meagan Montesion's work include Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Meagan Montesion is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Meagan Montesion collaborates with scholars based in United States, Italy and Australia. Meagan Montesion's co-authors include Garrett M. Frampton, John M. Coffin, Lee A. Albacker, Zachary H. Williams, Karthikeyan Murugesan, Daniel A. Laheru, Elizabeth M. Jaffee, Alexander C. Hopkins, Nilofer S. Azad and Mark Yarchoan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Meagan Montesion

43 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

2019 386 citations Mark Yarchoan, Lee A. Albacker et al. JCI Insight profile →
Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation

2023 75 citations Smruthy Sivakumar, Jay A. Moore et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meagan Montesion United States	16	773	574	330	306	253	46	1.4k
Véronique Winnepenninckx Netherlands	23	985 1.3×	935 1.6×	217 0.7×	270 0.9×	90 0.4×	67	2.0k
Rachel Erlich United States	19	592 0.8×	1.0k 1.8×	585 1.8×	337 1.1×	82 0.3×	39	2.1k
Sara R. Selitsky United States	21	557 0.7×	937 1.6×	222 0.7×	528 1.7×	69 0.3×	45	1.9k
Andrew S. Brohl United States	22	1.2k 1.6×	426 0.7×	528 1.6×	218 0.7×	48 0.2×	100	2.0k
Aaron R. Thorner United States	26	694 0.9×	1.1k 1.9×	582 1.8×	524 1.7×	65 0.3×	55	2.2k
David Roulois France	13	439 0.6×	887 1.5×	110 0.3×	164 0.5×	121 0.5×	20	1.5k
Kerstin Heselmeyer‐Haddad United States	21	612 0.8×	717 1.2×	219 0.7×	748 2.4×	98 0.4×	47	1.7k
Mark Egan United Kingdom	17	372 0.5×	701 1.2×	147 0.4×	179 0.6×	97 0.4×	27	1.4k
Anne I.J. Arens Netherlands	18	552 0.7×	897 1.6×	134 0.4×	139 0.5×	47 0.2×	49	1.6k
Aaron Bossler United States	21	353 0.5×	492 0.9×	271 0.8×	185 0.6×	23 0.1×	53	1.4k

Countries citing papers authored by Meagan Montesion

Since Specialization

Citations

This map shows the geographic impact of Meagan Montesion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meagan Montesion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meagan Montesion more than expected).

Fields of papers citing papers by Meagan Montesion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meagan Montesion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meagan Montesion. The network helps show where Meagan Montesion may publish in the future.

Co-authorship network of co-authors of Meagan Montesion

This figure shows the co-authorship network connecting the top 25 collaborators of Meagan Montesion. A scholar is included among the top collaborators of Meagan Montesion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meagan Montesion. Meagan Montesion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dharia, Neekesh V., Tomi Jun, Julie Chang, et al.. (2024). Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors. Clinical Cancer Research. 30(17). 3788–3797. 9 indexed citations

Sharaf, Radwa, Dexter X. Jin, John P. Grady, et al.. (2023). A pan-sarcoma landscape of telomeric content shows that alterations in RAD51B and GID4 are associated with higher telomeric content. npj Genomic Medicine. 8(1). 26–26. 5 indexed citations

Sivakumar, Smruthy, Jay A. Moore, Meagan Montesion, et al.. (2023). Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation. Cancer Discovery. 13(7). 1572–1591. 75 indexed citations breakdown →

Okamura, Ryosuke, et al.. (2022). Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy. SHILAP Revista de lepidopterología. 5(4). 90–97. 23 indexed citations

Janovitz, Tyler, Douglas A. Mata, Meagan Montesion, et al.. (2022). Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma. Modern Pathology. 35(11). 1618–1623. 2 indexed citations

Huang, Richard S.P., Karthikeyan Murugesan, Meagan Montesion, et al.. (2021). Pan-cancer landscape of CD274 (PD-L1) copy number changes in 244 584 patient samples and the correlation with PD-L1 protein expression. Journal for ImmunoTherapy of Cancer. 9(5). e002680–e002680. 16 indexed citations

Harvey, Michael J., et al.. (2021). Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non–Small-Cell Lung Cancer. JCO Precision Oncology. 5(5). 1611–1624. 13 indexed citations

Murugesan, Karthikeyan, Radwa Sharaf, Meagan Montesion, et al.. (2021). Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma. JCO Precision Oncology. 5(5). 1285–1296. 12 indexed citations

Williams, Erik A., Radwa Sharaf, Brennan Decker, et al.. (2020). CDKN2C -Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53 / RB1 –Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion. JCO Precision Oncology. 4(4). 955–971. 10 indexed citations

10.

Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles. Modern Pathology. 33(8). 1466–1474. 32 indexed citations

11.

Williams, Erik A., Meagan Montesion, Brian M. Alexander, et al.. (2020). CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features. Modern Pathology. 34(2). 358–370. 12 indexed citations

12.

Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations. Modern Pathology. 33(12). 2397–2406. 20 indexed citations

13.

Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma. Modern Pathology. 33(12). 2614–2625. 9 indexed citations

14.

Goodman, Aaron M., Shumei Kato, Ranajoy Chattopadhyay, et al.. (2019). Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness. Cancer Immunology Research. 7(6). 866–873. 22 indexed citations

15.

Knepper, Todd C., Meagan Montesion, Jeffery S. Russell, et al.. (2019). The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy. Clinical Cancer Research. 25(19). 5961–5971. 111 indexed citations

16.

Yarchoan, Mark, Lee A. Albacker, Alexander C. Hopkins, et al.. (2019). PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers. JCI Insight. 4(6). 386 indexed citations breakdown →

17.

Montesion, Meagan, Thomas Botton, Eric A. Collisson, et al.. (2018). Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion. The Oncologist. 23(9). 998–1003. 3 indexed citations

18.

Goldberg, Michael E., Meagan Montesion, Lauren Young, et al.. (2018). Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC. PLoS ONE. 13(11). e0208097–e0208097. 15 indexed citations

19.

Sun, James, Yuting He, Eric M. Sanford, et al.. (2018). A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal. PLoS Computational Biology. 14(2). e1005965–e1005965. 177 indexed citations

20.

Montesion, Meagan, et al.. (2018). Promoter expression of HERV-K (HML-2) provirus-derived sequences is related to LTR sequence variation and polymorphic transcription factor binding sites. Retrovirology. 15(1). 57–57. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact